medical leave

Steve Jobs, iCloud Still Won't Boost Apple's Stock

Steve Jobs received a standing ovation at Apple's annual Worldwide Developers Conference Monday as the company unveiled its iCloud hosted computing service. But despite Jobs' anticipated participation, investors should not expect a huge upswing in the company's stock, one expert says.

Two Drugs Found to Fight Steve Jobs' Rare Cancer Type

Pfizer's cancer drug Sutent and Novartis's drug Afinitor have both been found to be effective against the rare form of pancreatic cancer that Apple CEO Steve Jobs was diagnosed with in 2004, according to two studies published in the New England Journal of Medicine.

Why Jobs's Absence May Not Keep Apple Shares Down Long

Twice before the iconic CEO had to leave the company in others' hands, and if that history is any guide, Apple investors may see the stock price do well once again in his absence -- providing they can handle the pain of the drop long enough to enjoy the recovery.